ABAstrid D. H. Brys

Astrid D. H. Brys

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Astrid D. H. Brys has a total of 80 co-authors. Here are the top co-authors by number of shared publications:

  • Bert Lenaert

    Department of Neuropsychology and Psychopharmacology, Faculty of Psychology and Neuroscience, Maastricht University, Maastricht, The Netherlands; School for Mental Health and Neuroscience, Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands; Limburg Brain Injury Centre, The Netherlands

    5 shared publications
  • Maurizio Bossola

    Università Cattolica del Sacro Cuore, Roma, Italia; Hemodialysis Unit, Università Cattolica del Sacro Cuore, Rome, Italy

    4 shared publications
  • Enrico Di Stasio

    Università Cattolica del Sacro Cuore, Rome, Italy; UOC Chimica, Biochimica e Biologia Molecolare Clinica, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy

    3 shared publications
  • Giovanni Gambaro

    Divisione di Nefrologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy; Division of Nephrology, University Hospital of Verona, Verona, Italy

    3 shared publications
  • Giovanni Gambaro

    Division of Nephrology, Department of Medicine, University of Verona , Verona

    3 shared publications
  • Nele Van Den Noortgate

    Department of Internal Medicine and Pediatrics, Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium

    3 shared publications

Latest Publications

  • Open Access

    A Cross-Sectional Study on Healthcare Providers’ Perceived Compassion and Emotional Exhaustion Across Five Acute Geriatric Units: The Importance of Mutual Respect and Open Reflection

    by Ruth Piers, Judith Hanssens, Jolien De Vos, Katrien Cobbaert, Inge Pattyn, Katrien Van Puyvelde, Barbara Vandervennet, Jille Gelders, Astrid Brys, Anja Velghe, et al.

    Background/Objectives: Despite growing evidence on the importance of compassionate care, it receives little attention in geriatrics literature. The aim is to study the variation and key components of team compassionate care and its relation to individual healthcare provider (HCP) emotional exhaustion in acute geriatric units (AGUs). Methods: A cross-sectional survey study, from February to April 2025, with a convenience sample of HCPs in five Belgian AGUs (70% response rate). Validated questionnaires were used: The Sinclair Compassion Questionnaire (SCQ), Emotional Exhaustion (EE) subscale of Maslach Burnout Inventory and Ethical Decision-Making Climate Questionnaire (EDMCQ). Results: In total, 118 HCPs participated: 11% team leaders, 28% paramedics, 61% nursing professionals. Mean AGU SCQ scores ranged from 3.62 to 4.28 on a scale from one (lowest) to five (highest). Multivariate linear regression models showed significant differences in team compassion scores across AGUs (estimate 0.084, p = 0.003) and increased with higher ethical climate scores (estimate per point on the EDMCQ 0.035, p < 0.001). Two EDMCQ domains (open interprofessional reflection and mutual respect) were associated with team compassionate care beyond the effect of AGUs, whereas demographics and self-reported emotional exhaustion were not (R2 = 0.283). Emotional exhaustion was significantly associated with professional role (estimate −3.004, p = 0.011), but not with AGUs (estimate 0.768, p = 0.269), ethical climate (estimate per point on the EDMCQ −0.248, p = 0.117) and team-based compassion scores (R2 = 0.115). Nursing professionals were significantly at higher risk for emotional exhaustion compared to paramedics (estimate 4.497, p = 0.037). Conclusions: The level of team compassionate care differed across AGUs and was correlated to the perceived ethical climate of the workplace, and not to individual HCP demographic variables or emotional exhaustion. Mutual respect and open interprofessional reflection may be specific areas for future research in improving high-quality compassionate care.

  • Open Access

    Potentially Clinically Significant Drug-Drug Interactions in Older Adults with Atrial Fibrillation and Multimorbidity: Prevalence, Correlates, and Association with Adverse Clinical Outcomes in a Swedish National Register-Based Study

    by Cheima Amrouch, Davide Liborio Vetrano, Dirk De Bacquer, Nicola Ferri, Ine Simal, Cecilia Damiano, Lu Dai, Amaia Calderón-Larrañaga, Astrid D. H. Brys, Anton De Spiegeleer, et al.

    Purpose Current research on potentially clinically significant drug-drug interactions (DDIs) in individuals with atrial fibrillation (AF) has predominantly focused on DDIs involving direct oral anticoagulants (DOACs), with limited evidence regarding other medications. Our study aimed to: (i) assess the overall prevalence of DDIs; (ii) investigate potential demographic correlates of DDIs; and (iii) examine the association of DDIs with adverse clinical outcomes in a nationwide cohort of older adults with AF and multimorbidity. Methodology Data from the Swedish national registers were linked to establish a cohort with a 2-year follow-up of adults ≥ 65 years who, on 1 January 2017, had a diagnosis of AF, ≥ 1 comorbidity and were prescribed ≥ 2 medications (n = 192,716). This study describes the prevalence of 72 potentially clinically significant DDIs from an adapted explicit international consensus list and a review focused specifically on DDIs involving DOACs. Correlates of DDIs were assessed through logistic regressions. Cox regression analyses were conducted to examine the association between DDIs and adverse clinical outcomes: overall and cardiovascular (CV) mortality, overall and CV hospitalisation, stroke, bleeding, and falls. Results In the overall population, 37.5% presented with ≥ 1 potential DDI, with CV (33.8%) and central nervous system (CNS) drugs (12.4%) most frequently involved. Sex, age, and civil status were most consistently associated with DDIs. Individuals with ≥ 1 DDI had a higher hazard of CV death (hazard ratio 1.28 95% confidence interval (CI) [1.24–1.32]), CV hospitalisation (1.12 [1.10–1.15]) and falls (1.06 [1.02–1.09]). DDIs with DOACs were associated with gastrointestinal bleeding (2.80 [1.35–5.81]). DDIs with CNS drugs were associated with stroke (1.19 [1.09–1.29]) and falls (1.32 [1.27–1.39]). Conclusion Potentially clinically significant DDIs were prevalent in older adults with AF and multimorbidity, with adverse clinical implications. Identifying these high-risk groups is essential for preventive strategies and effective clinical management.


  • Risk factors for suboptimal target attainment of commonly used ß-lactam antibiotics in older adults: a prospective cohort study

    by Arnaud De Clercq, Tania Desmet, Jerina Boelens, Annemie Somers, Veronique Stove, Nick Verougstraete, Astrid Brys, Mirko Petrovic, Peter De Paepe, Pieter A De Cock

    Objectives: Age-related pathophysiological changes may impact the pharmacokinetics and pharmacodynamics (PK/PD) of ß-lactam antibiotics, potentially resulting in suboptimal concentrations in older adults. This study evaluated PK/PD target attainment with current intravenous amoxicillin-clavulanate and piperacillin-tazobactam dosing regimens in older adults, identified risk factors for target non-attainment, and assessed the prevalence of toxic concentrations. Methods: This was a prospective, observational PK study in geriatric inpatients (≥75 years) who were treated intravenously with amoxicillin-clavulanate (1 g/0.2 g q6h as a 30-minute infusion) or piperacillin-tazobactam (4 g/0.5 g q6h as a 3-hour infusion). Trough blood samples were collected in steady-state conditions. Target attainment was evaluated against a 100%fT > MIC target. Risk factors for target non-attainment were identified by multivariable logistic regression analysis. Toxicity thresholds were defined as total Cmin concentrations of 80 mg/L for amoxicillin and 157.2 mg/L for piperacillin. Results: Seventy-four patients (median age (IQR): 87 years (83–90)) were included. The PK/PD target was achieved in 15 of 35 and 33 of 39 patients for amoxicillin-clavulanate and piperacillin-tazobactam, respectively. Multivariable logistic regression analysis revealed an effect of comorbidity burden, assessed by the Cumulative Illness Rating Scale-Geriatric (CIRS-G), and estimated glomerular filtration rate that explained 23.8% of target non-attainment (P < 0.05). Receiver operator characteristic curves identified an eGFR of 67 mL/min/1.73m2 as a threshold associated with an increased risk of target non-attainment. Toxicity thresholds were never exceeded in this study. Conclusions: Health status and renal function, rather than chronological age, play a significant role in target non-attainment among older adults. Further research is required to delineate predictors for interpatient variability in PK and develop evidence-based dosing strategies. Trial registration: Registration in ClinicalTrials.gov Trial registration number: NCT04436991 Registration date: 16/06/2020

  • Open Access

    Validation and performance of a geriatric early warning score (GEWS) versus the national early warning score (NEWS) in predicting clinical deterioration in frail older patients

    by H. Baeyens, F. Haegdorens, S. Martens, M. E. Vanden Abeele, S. Wallaert, N. Van Den Noortgate, A. D. H. Brys

    Purpose: A Geriatric Early Warning Score (GEWS) for detecting clinical deterioration in frail older individuals was developed to account for age-related altered physiological responses and was based on the framework of the National Early Warning Score (NEWS), expert consensus and existing literature. This study aimed to validate GEWS and compare its predictive accuracy with the NEWS, as well as to evaluate the clinical burden of predefined thresholds. Methods: In this prospective multicenter observational study, patients receiving acute geriatric care were included. Clinical deterioration was defined as: (1) unexpected death, (2) Intensive Care Unit transfer, (3) transition to palliative care, or (4) urgent medical/surgical intervention. Results: Among 511 patients, 348 events occurred in 297 individuals. We found higher AUROC 0.796 [95% CI 0.770–0.822] and PR-AUC values 0.412 [95% CI 0.350–0.472] for GEWS compared to NEWS 0.732 [95% CI 0.697–0.765] and 0.305 [95% CI 0.249–0.365] respectively ( p < 0.0001). The GEWS ≥ 5 compared to NEWS ≥ 5 was superior in accuracy (0.940 vs. 0.927), PPV (0.497 vs. 0.365), and specificity (0.977 vs. 0.967), (all p < 0.0001). Moreover, a lower-number-needed-to-evaluate (NNE) (2.013 vs. 2.738, p < 0.0001) and a higher alerted-outcome-event-rate (AOER 4.424 vs. 3.706, p < 0.0005) resulted in lower clinical burden. For life-threatening events (Type 1–3), GEWS ≥ 8 compared to NEWS ≥ 7 showed higher specificity (0.999 vs. 0.995, p < 0.0001) and reduced rate-of-alerts (ROA 0.518 vs.1.347, p < 0.0001). Conclusion: GEWS more accurately detects clinical deterioration within 12 h in frail older adults than NEWS, with less clinical burden. GEWS ≥ 5 is recommended for clinical alerting, whereas ≥ 8 for more urgent medical assistance.


  • Open Access

    Validation and Performance of a Geriatric Early Warning Score (Gews) Versus the National Early Waring Score (News) in Predicting Clinical Deterioration in Frail Older Patients

    by Hilde Baeyens, Filip Haegdorens, Sven Martens, Marie-Elena Vanden Abeele, Steven Wallaert, Nele Van Den Noortgate, Astrid D.H. Brys

    Purpose: Early warning scores, such as the National Early Warning Score (NEWS), are less accurate in detecting clinical deterioration in frail older individuals due to age-related altered physiological responses. A Geriatric Early Warning Score (GEWS) was developed to take into account older adults’ frailty. This study aimed to validate GEWS and compare its predictive accuracy with NEWS, as well as to evaluate the clinical burden of GEWS. Methods: In this prospective multicenter observational study, patients admitted to acute geriatric wards were included. Clinical deterioration was defined as the occurrence of one of four events: (1) unexpected death, (2) ICU transfer, (3) transition to palliative care, or (4) urgent medical/surgical intervention. GEWS and NEWS were compared using C-statistics, performance and clinical burden metrics. Results: Among 511 patients, 348 events were recorded in 302 individuals. GEWS significantly outperformed NEWS across all event types, showing higher AUROC and PR-AUC values (p<0.0001). At a GEWS threshold ≥5, predictive performance was superior in accuracy (0.940 vs. 0.927), PPV (0.497 vs. 0.365), and specificity (0.977 vs 0.967), all p<0.0001. GEWS ≥5 was also associated with a lower clinical burden (NNE: 2.013 vs 2.738, p<0.0001). For life-threatening events (Type 1-3), GEWS ≥8 provided higher specificity (0.999 vs. 0.995, p<0.0001) and a reduced alarm rate (0.518 vs.1.347, p<0.0001). Conclusion: GEWS offers a more accurate, geriatric-specific alternative to NEWS for detecting clinical deterioration in frail older adults, while reducing clinical workload. A threshold of GEWS ≥5 is recommended for clinical alerting, whereas ≥8 for rapid response team activation.


  • Open Access

    Geriatric Assessment in Older Patients with Advanced Kidney Disease: A Key to Personalized Care and Shared Decision-Making—A Narrative Review

    by Elisabeth J. R. Litjens, Melanie Dani, Wouter R. Verberne, Nele J. Van Den Noortgate, Hanneke M. H. Joosten, Astrid D. H. Brys

    As the global population ages, so too does the prevalence of older people with chronic kidney disease (CKD). Helping people age well with CKD and supporting older people with end-stage kidney disease (ESKD) to make personalized decisions regarding kidney replacement therapy (KRT) or conservative care (CC) are an essential component of care. However, these factors are relatively underreported in both the fields of nephrology and geriatric medicine, and prospective, randomized evidence is lacking. This narrative review article, authored by both nephrologists and geriatricians, discusses specific geriatric issues that arise in older people with CKD and why they matter. The available evidence for KRT or CC in older people with frailty is outlined. The importance of performing a comprehensive geriatric assessment, or a modified nephrogeriatric assessment, to ensure a systematic evaluation of the person’s medical problems and life needs, goals, and values is described. We consider different models of nephrogeriatric care and how they may be implemented. Kidney supportive care—addressing an individual’s symptoms and overall well-being alongside the more traditional nephrological principles of preventing disease progression and optimizing risk—is highlighted throughout the article. We outline ways of identifying the later stages of a person’s disease journey, when transition to palliative care is indicated, and elaborate methods of preparing patients for this through multidisciplinary advance care planning. Finally, we discuss practice and systems for nephrogeriatric care in five different European countries and consider future directions, challenges, and highlights in this rapidly evolving, increasingly relevant field.


  • Open Access

    The Feasibility of Semi-Continuous and Multi-Frequency Thoracic Bioimpedance Measurements by a Wearable Device during Fluid Changes in Hemodialysis Patients

    by Melanie K. Schoutteten, Lucas Lindeboom, Hélène De Cannière, Zoë Pieters, Liesbeth Bruckers, Astrid D. H. Brys, Patrick van der Heijden, Bart De Moor, Jacques Peeters, Chris Van Hoof, et al.

    Repeated single-point measurements of thoracic bioimpedance at a single (low) frequency are strongly related to fluid changes during hemodialysis. Extension to semi-continuous measurements may provide longitudinal details in the time pattern of the bioimpedance signal, and multi-frequency measurements may add in-depth information on the distribution between intra- and extracellular fluid. This study aimed to investigate the feasibility of semi-continuous multi-frequency thoracic bioimpedance measurements by a wearable device in hemodialysis patients. Therefore, thoracic bioimpedance was recorded semi-continuously (i.e., every ten minutes) at nine frequencies (8–160 kHz) in 68 patients during two consecutive hemodialysis sessions, complemented by a single-point measurement at home in-between both sessions. On average, the resistance signals increased during both hemodialysis sessions and decreased during the interdialytic interval. The increase during dialysis was larger at 8 kHz (∆ 32.6 Ω during session 1 and ∆ 10 Ω during session 2), compared to 160 kHz (∆ 29.5 Ω during session 1 and ∆ 5.1 Ω during session 2). Whereas the resistance at 8 kHz showed a linear time pattern, the evolution of the resistance at 160 kHz was significantly different (p < 0.0001). Measuring bioimpedance semi-continuously and with a multi-frequency current is a major step forward in the understanding of fluid dynamics in hemodialysis patients. This study paves the road towards remote fluid monitoring.


  • Open Access

    The Feasibility of Semi-continuous and Multifrequency Thoracic Bioimpedance Measurements by a Wearable Device during Fluid Changes in Hemodialysis Patients

    by Melanie Kristien Schoutteten, Lucas Lindeboom, Hélène De Cannière, Zoë Pieters, Liesbeth Bruckers, Astrid Brys, Patrick Van der Heijden, Bart De Moor, Jacques Peeters, Chris Van Hoof, et al.

    Repeated single-point measurements of thoracic bioimpedance at single (low)-frequency are strongly related to fluid changes during hemodialysis. Extension to semi-continuous measurements may provide longitudinal details in the time pattern of the bioimpedance signal, and multifrequency measurements may add in-depth information on the distribution between intra- and extracellular fluid. This study aims to investigate the feasibility of semi-continuous multifrequency thoracic bioimpedance measurements by a wearable device in hemodialysis patients. Therefore, thoracic bioimpedance was recorded semi-continuously (i.e. every ten minutes) at nine frequencies (8 – 160 kHz) in 68 patients during two consecutive hemodialysis sessions, complemented by a single-point measurement at home in-between both sessions. On average, the resistance signals increased during both hemodialysis sessions and decreased during the interdialytic interval. The increase during dialysis was larger at 8 kHz (∆ 32.6 Ω during session 1 and ∆ 10 Ω during session 2) compared to 160 kHz (∆ 29.5 Ω during session 1 and ∆ 5.1 Ω during session 2). Whereas the resistance at 8 kHz showed a linear time pattern, the evolution of the resistance at 160 kHz was significantly different [p < 0.0001]. Measuring bioimpedance semi-continuously and with a multifrequency current is a major step forward in the understanding of fluid dynamics in hemodialysis patients. This study paves the road towards remote fluid monitoring.


  • Open Access

    Not all is what it seems like: Hypercalcemia in the older patient

    by Astrid D.H.M. Brys, Coen D.A. Stehouwer, Christina van de Weijer, Fabienne Magdelijns

  • Unraveling Fatigue in Hemodialysis Patients: Comparing Retrospective Reports to Real-Time Assessments With an mHealth Experienced Sampling Method

    by Astrid D.H. Brys, Frank Stifft, Caroline M. Van Heugten, Maurizio Bossola, Giovanni Gambaro, Bert Lenaert